Year: All Releases20192018201720162015201420132012 November 8, 2019 Mersana Therapeutics Presents New Preclinical Data from Immunosynthen Platform at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting PDF Version November 6, 2019 Mersana Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Updates PDF Version October 30, 2019 Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2019 Financial Results and Business Updates PDF Version September 27, 2019 Mersana Therapeutics to Present at the 2019 Cantor Global Healthcare Conference PDF Version August 28, 2019 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version August 20, 2019 Mersana Therapeutics Announces Initiation of Expansion Study of XMT-1536 in Patients with Platinum-Resistant Ovarian Cancer and Non-Small Cell Lung Cancer PDF Version August 8, 2019 Mersana Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Updates PDF Version August 6, 2019 Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference PDF Version August 1, 2019 Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2019 Financial Results and Business Updates PDF Version June 12, 2019 Mersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
